SYSTEM; LUPUS ERYTHEMATOSUS
Clinical trials for SYSTEM; LUPUS ERYTHEMATOSUS explained in plain language.
Never miss a new study
Get alerted when new SYSTEM; LUPUS ERYTHEMATOSUS trials appear
Sign up with your email to follow new studies for SYSTEM; LUPUS ERYTHEMATOSUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Stem Cell-Derived 'Living Drug' takes aim at tough autoimmune conditions
Disease control Not yet recruitingThis early-phase trial will test BCT301, a type of immune cell made from stem cells, in 10 people with severe autoimmune diseases like lupus and scleroderma. Participants receive a single infusion of these cells after a short course of chemotherapy. The main goal is to check safe…
Matched conditions: SYSTEM; LUPUS ERYTHEMATOSUS
Phase: EARLY_PHASE1 • Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Gene clues could unlock better diagnosis for blood disorders
Knowledge-focused Not yet recruitingThis study looks at two genes (IL-1β and IL-33) in 300 adults with low platelet counts caused by either primary immune thrombocytopenia (ITP) or lupus (SLE). Researchers will measure gene activity from a blood sample to see if these genes can help tell the two conditions apart. T…
Matched conditions: SYSTEM; LUPUS ERYTHEMATOSUS
Sponsor: Sohag University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC